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Background and Objectives: Endoscopic retrograde
cholangiopancreaticography has been reported to have a
high success rate in the detection and treatment of chole-
docholithiasis.  Although there is growing enthusiasm for
laparoscopic common bile duct clearance, many patients
who present with gallbladder disease and suspected
choledocholithiasis have endoscopic retrograde cholan-
giopancreatography performed with choledocholithiasis
cleared if detected.  These patients are then referred for
laparoscopic cholecystectomy.  The purpose of this study
is to determine the efficacy of preoperative endoscopic
retrograde cholangiopancreatography in the diagnosis
and clearance of bile duct stones at our institution.
Methods: A retrospective review was performed of all
patients at this institution who underwent preoperative
endoscopic retrograde cholangiopancreatography for
suspected choledocholithiasis followed by laparoscopic
cholecystectomy from January 1997 through July 1998.
Results: Common bile duct stones were detected endo-
scopically in 12 of 17 (71%) patients.  We found serum
bilirubin level to be the best predictor of choledo-
cholithiasis.  In 12 of 12 procedures, the endoscopist per-
formed an endoscopic sphincterotomy with stone extrac-
tion and reported a fully cleared common bile duct.
Intraoperative cholangiogram performed during subse-
quent cholecystectomy revealed choledocholithiasis in 4
of these 12 patients.  Laparoscopic techniques success-
fully cleared the choledocholithiasis in 3 of these patients
with open techniques necessary in the fourth.
Conclusions: Our data suggests that even after pre-
sumed successful endoscopic clearance of the bile duct
stones, many patients (33% in our series) still have chole-
INTRODUCTION
Although laparoscopic cholecystectomy (LC) has become
the standard for gallbladder removal, there is still debate
as to the most effective and efficient method of clearing
choledocholithiasis.  One frequent clinical scenario in
which the clinician must decide the most appropriate
treatment methodology is the patient with preoperatively
suspected choledocholithiasis.  Options include open
common bile duct (CBD) exploration, laparoscopic CBD
clearance with postoperative endoscopic retrograde
cholangiopancreaticography (ERCP) or open CBD explo-
ration reserved for laparoscopic failures.  Another
approach is preoperative ERCP followed by LC.  Because
of the higher morbidity associated with open cholecys-
tectomy compared to LC, open CBD exploration as a first-
line therapy for patients with suspected choledocholithia-
sis has fallen out of favor.  As surgeons have improved
their laparoscopic skills and laparoscopic technology con-
tinues to advance, there has been a steady increase in the
number of series promoting laparoscopic CBD techniques
as the initial procedure of choice in patients suspected of
having CBD stones.1-9 In this treatment plan, if laparo-
scopic techniques fail, the surgeon must either convert to
open CBD exploration with increased morbidity or rely
on postoperative ERCP.  Many centers do not have the
laparoscopic technology or expertise to reliably clear
CBD stones.  In other centers, timely postoperative ERCP
is difficult to obtain from a logistical standpoint.  Thus,
many institutions still rely on preoperative ERCP in cases
of suspected CBD stones.10,11
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docholithiasis present at the time of cholecystectomy.
We  recommend intraoperative cholangiography at the
time of cholecystectomy even after presumed successful
endoscopic retrograde cholangiopancreatography with
further intervention, preferably laparoscopic, to clear the
choledocholithiasis as deemed necessary.
Key Words: Choledocholithiasis, Preoperative endo-
scopic retrograde cholangiopancreatography,
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Advocates of preoperative ERCP are many.12-22  However,
a liberal use of preoperative ERCP based on risk factors
for choledocholithiasis can result in a high number of
nontherapeutic ERCPs (25-76%).11-13,18,21-27 Well estab-
lished risk factors for CBD stones include age, cholangi-
tis, jaundice, elevated liver function tests (LFTs), gallstone
pancreatitis, a prior history of CBD stones, and ultra-
sonography (US) findings of choledocholithiasis or a
dilated CBD.28,29 Recently, much effort has been expend-
ed to better define the clinical risk factors that most accu-
rately predict CBD stones in order to avoid unnecessary
ERCPs.13,30-34 The results have not been consistent.
Some have found US findings necessary to develop a
good predictive model,11,35,36 while others have found US
findings to be an unreliable predictor of CBD stones.37
Several series conclude that only a combination of ele-
vated LFTs and US findings will most accurately predict
CBD stones.13,28,32
In our institution, we do not have postoperative ERCP
readily available, and we are still in the process of devel-
oping our laparoscopic CBD expertise.  Thus, patients
whom we feel are at high risk for CBD stones are sub-
jected to preoperative ERCP with endoscopic sphinctero-
tomy and stone extraction, as indicated, followed by LC.
In this series, we analyze the accuracy of our clinical risk
factors in predicting CBD stones, the success of preoper-
ative ERCP at clearing the CBD, and, if CBD stones were
left behind after ERCP (detected on intraoperative cholan-
giography), whether we were able to clear them laparo-
scopically.
MATERIALS AND METHODS
The medical records of all patients at Kern Medical
Center with gallbladder disease who had preoperative
ERCP for suspected choledocholithiasis from January
1997 through July 1998 were reviewed.  Each patient’s
age, sex, clinical presentation including laboratory values
and US findings were recorded.  The specific findings
that led the physician to suspect choledocholithiasis and
prompted preoperative ERCP were noted.  The ERCP
procedure details, findings and conclusions were exam-
ined, as were the intraoperative finding and procedure
details.  We recorded whether CBD stones were found
during ERCP and, if present, how these stones were
cleared.  We also noted whether the endoscopist felt
CBD stone clearance was complete or not.  Any compli-
cation related to ERCP was noted.  All patients had LC
performed within 24 hours of ERCP.  Intraoperative
cholangiogram findings were analyzed as to the presence
of CBD stones and, if present, whether they were cleared
successfully.  The intraoperative techniques to clear the
CBD were noted.
RESULTS
Seventeen patients had preoperative ERCP for suspected
choledocholithiasis, followed by LC over the 19-month
period reviewed.  The mean age of patients with con-
firmed CBD stones was 33 years (range 15-58) and 38
years (range 22-54) in patients with no CBD stones found
on ERCP.  Four of the 17 patients were males.  All
Table 1.
Risk factors in patients with no CBD stone found on ERCP.
PATIENT SB ≠ AP  ≠ GSP CBD STONE US CBD DILATED ON US
1* Yes Yes Yes
2† Yes Yes
3† Yes Yes Yes
4† Yes Yes
5† Yes
*Patient admitted to General Surgery.
†Patient admitted to Internal Medicine.
SB=serum bilirubin; AP=alkaline phosphatase; GSP=gallstone pancreatitits; US=ultrasound; CBD=common bile duct.patients were admitted to the hospital for acute biliary
symptoms.  Clinical presentations included 7 patients
with biliary pancreatitis, 2 with cholangitis, and 8 with
symptomatic cholelithiasis plus suspected biliary obstruc-
tion.  Gallstones were visualized on US in 15 of 17
patients.  The endoscopist was able to successfully can-
nulate the papillae and complete the ERCP in all 17
patients.  There were no complications or deaths related
to the endoscopic procedure in this series.
Reasons for suspected choledocholithiasis that led to pre-
operative ERCP included gallstone pancreatitis in 7, ele-
vated serum bilirubin level (>1.7 mg/dl) in 13, elevated
alkaline phosphatase  level (>107 U/L) in 14, US finding
of choledocholithiasis in 3 and dilated CBD in 10 (>7
mm).  Sixteen of 17 patients had more than one of the
above risk factors for choledocholithiasis present at
admission (Tables 1 and 2).
No CBD stones were found on ERCP in 5 of 17 patients
(29%).  Of these 5 patients, the intraoperative cholan-
giogram confirmed no choledocholithiasis in 2, while
cholangiogram was not performed in the other 3 (Figure
1).  The risk factors for choledocholithiasis, which were
present as well as those not present in the patients who
did not have CBD stones found on ERCP, are presented
in Table 1.
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Common bile duct stones were detected on ERCP in 12
of 17 patients (71%).  The risk factors for choledo-
cholithiasis, noted in these 12 patients, are presented in
Table 2.  In all 12 patients, sphincterotomy with stone
extraction was performed and, in each case, the endo-
scopist reported a fully cleared CBD.  Intraoperative
cholangiogram was performed during subsequent LC in
9 of the 12 patients who had stones found and report-
edly cleared by ERCP.  Choledocholithiasis was still pres-
ent in 4 of these 9 patients (Figure 1).  Laparoscopic
techniques (all transcystic) successfully cleared the CBD
in 3 patients.  The fourth patient required open CBD
exploration for successful clearance.
DISCUSSION
Before the introduction of LC, the use of ERCP in patients
with gallbladder disease was reserved for patients with
severe biliary pancreatitis, acute suppurative cholangitis,
poor operative candidates with suspected CBD stones or
for postoperative retained stones.  Open CBD explo-
ration added little to open cholecystectomy alone in
terms of morbidity or mortality.  However, open CBD
exploration compared to LC substantially lengthens mor-
bidity, hospital stay, and return to work time.  This has
resulted in much interest in methods to clear the CBD by
Table 2.
Risk factors in patients with CBD stone found on ERCP.
PATIENT SB ≠ AP ≠ GSP CBD STONE US CBD DILATED ON US
1* Yes Yes Yes
2* Yes Yes Yes Yes Yes
3* Yes Yes
4* Yes Yes
5* Yes Yes Yes
6* Yes Yes
7* Yes Yes Yes Yes
8* Yes Yes Yes
9* Yes Yes
10* Yes Yes Yes
11* Yes Yes Yes
12* Yes Yes Yes
*Patient admitted to General Surgery.
SB=serum bilirubin; AP=alkaline phosphatase; GSP=gallstone pancreatitits; US=ultrasound; CBD=common bile duct.The Efficacy of Preoperative Endoscopic Retrograde Cholangiopancreatography in the Detection and Clearance of Choledocholithiasis,
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less invasive means.  The major options when CBD
stones are suspected include preoperative ERCP, laparo-
scopic CBD clearance techniques, or postoperative ERCP
if laparoscopic methods fail or are not available.  The
optimal approach to patients with suspected CBD stones
is uncertain and depends upon local expertise in
laparoscopy, availability of equipment, as well as the
availability and expertise in ERCP.
In 1993, the NIH Consensus statement recommended pre-
operative ERCP or transhepatic cholangiography for all
patients with clinical suspicion for CBD stones.  This led
to a high number of therapeutic and nontherapeutic
ERCP’s.38 Several centers report ERCP to have a high
diagnostic success rate (76-97%)12,19,39-41 and an inability
to cannulate rate of just 5%.24,39 In our series, endo-
scopists had a cannulation rate of 100%.  Major centers
report impressive ductal clearance rates of more than
90%.11,12,26,42-44 However, Poole and Cuschieri pointed
out that data collected from major centers probably
underestimates the actual endoscopic stone extraction
failure rate and that, in European trials, the preoperative
ERCP ductal clearance failure rate is approximately
20%.10,45 Koo reported a small series in which endo-
scopists supposedly cleared the CBD of stones, yet 43%
were found to have residual stones on intraoperative
cholangiography.30 In our series, of the 12 patients
whom the endoscopist reported to have endoscopically
cleared the CBD stones, 4 (33%) were subsequently
found to have choledocholithiasis on intraoperative
cholangiography.  We suspect that the stones undetected
during ERCP were present in the intrahepatic ducts and
thus difficult to visualize.  Subsequently, these stones
migrated into the CBD and were successfully detected
during intraoperative cholangiography.
In an institution such as our own, in which ERCP is per-
formed prior to LC in patients with suspected CBD
stones, the critical element in avoiding unnecessary ERCP
and its inherent risk and cost is the effectiveness of CBD
stone prediction.  Complications of ERCP occur approxi-
mately 10% of the time, with a mortality rate of 1-3%.46-48
The most common of the complications, post-ERCP pan-
creatitis, occurs from 1-5.5% of the time, with 10% of
those who develop the complication requiring surgical
intervention.46,49 In our series, we were fortunate to
have no complications related to ERCP and no mortality.
The incidence of CBD stones in unselected patients
undergoing elective LC has been quoted as 5-20%.27,30,50-
55 However, in patients thought to be at low risk for
CBD stones, the rate of choledocholithiasis found on
routine intraoperative cholangiogram is reported to be
1.7%.26 To better define the most accurate clinical risk
factors for choledocholithiasis and thereby avoid subject-
ing patients to unnecessary preoperative ERCP, several
models have been developed.  Barkin found that a com-
bination of risk factors including age, elevated bilirubin,
and US findings of a dilated duct and a CBD stone pro-
duced a 94% specificity of CBD stone presence.32 He
also found that if all four risk factors were absent, then
the chance of a CBD stone being present was only 8%.32
His model is clinically limited because most patients do
not have all four risk factors either present or absent.
Robertson’s model using age, jaundice, albumin, and US
findings produced a 75% specificity and 89% sensitivity
for CBD stones.13 Trondsen developed a model using
age and a combination of several LFTs to accurately pre-
dict CBD stones with a 3.7% false positive rate and a
1.8% false negative rate.33 Robertson and Lacaine both
concluded that of all the LFTs, alkaline phosphatase was
the most important in predicting CBD stones, but
Robertson emphasized that a single elevated LFT was not
a good predictor.13,31 Saltztein found that the only com-
bination of risk factors that accurately predicted CBD
stones was a combination of elevated bilirubin and ele-
Figure 1. Patients with suspected choledocholithiasis who
underwent ERCP prior to laparoscopic cholecystectomy.
CBD=common bile duct; IOC=intraoperative cholangiogram.
17
5 ERCP - 12 ERCP +
1 CBD CLEARED BY
OPEN TECHNIQUE
2 IOC CLEAR 3 NO IOC DONE
12 CBD “CLEARED” BY ERCP
9 IOC 3 NO IOC
4 + CBD STONES 5 - CBD STONES
3 CBD CLEARED
BY LAPAROSCOPYvated alkaline phosphatase.34 In our series, we found a
normal serum bilirubin to be the best predictor of the
absence of CBD stones with a false negative rate of 0/4
(0%).  Of the 4 patients who had a normal bilirubin but
other risk factors present, none were found to have CBD
stones (Table 1).  An elevated bilirubin level in our series
was the best predictor of the presence of CBD stones.  A
total of 13 patients had an elevated bilirubin and, of
those, 12 of 13 (92%) had CBD stones found (a false pos-
itive rate of 8%).  In this series, LFTs other than bilirubin
did not accurately predict CBD stones, nor did age.
Three patients had a normal alkaline phosphatase and, of
those, one had a CBD stone (a false negative rate of 33%).
Fourteen patients had an elevated alkaline phosphatase,
but only 11 had CBD stones (a false positive rate of 21%).
In our series, biliary dilatation found on US had a 22%
false positive rate (2/9), while a normal-sized ductal sys-
tem did not accurately predict the absence of CBD stones
(false negative rate of 63%).  Interestingly, each of the
three patients who had false positive US findings also had
a normal bilirubin, further supporting the negative pre-
dictive value of a normal bilirubin.
Many authors have demonstrated the overall low inci-
dence of CBD stones found in gallstone pancreatitis
patients, especially if one delays ERCP or intraoperative
cholangiography for more than 48 hours from the time of
presentation or until the pancreatitis has resolved.12,56-59
Others have concluded that preoperative ERCP in patients
with biliary pancreatitis is only warranted for persistent
elevation of LFTs or in patients with severe pancreatitis
who do not quickly improve.60 Our findings support
these observations.  In our 7 biliary pancreatitis patients,
only 3 (43%) had CBD stones detected and, of those, all
3 had an elevated serum bilirubin level, further support-
ing the predictive value of bilirubin in our institution.  In
total, of the 17 patients subjected to preoperative ERCP,
12 were confirmed to have choledocholithiasis (71%).  Of
note, at our institution, the Department of Surgery typi-
cally obtains preoperative ERCP based on a persistently
elevated bilirubin level.  Of the 5 patients who were
found to have no CBD stones (received unnecessary pre-
operative ERCP), 4 were admitted to the Internal
Medicine service.  They each had a normal serum biliru-
bin, but preoperative ERCP was ordered based on the
presence of other risk factors.  Had these patients been
on the Surgery service, they most likely would not have
had preoperative ERCP because they had a normal serum
bilirubin.
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We, like others, have found laparoscopic CBD clearance
an effective alternative to open CBD exploration.1,2,8
Advances in technology, as well as advanced laparoscop-
ic skills, have made possible transcystic and, more recent-
ly, supraduodenal choledochotomy with CBD clear-
ance.3,4,9 As the success rate of laparoscopic CBD clear-
ance has improved to more than 80%, many surgeons
bypass the preoperative ERCP in patients with suspected
CBD stones and, if found on intraoperative cholangiogra-
phy, CBD stones are cleared laparoscopically.2,5-8
Erickson, using decision tree analysis and existing data in
the literature, determined that the best management
scheme in terms of cost and morbidity in patients with
predicted CBD stones was laparoscopic CBD clearance
with postoperative ERCP reserved for laparoscopic fail-
ures.  If the ability of the institution to accurately predict
CBD stones was high, preoperative ERCP followed by
laparoscopic CBD exploration for ERCP failures was an
equally effective strategy.  Finally, he found that if post-
operative ERCP was not readily available, then preopera-
tive ERCP followed by LC was the preferred approach.61
Others, like us, reserve laparoscopic CBD techniques for
unexpected choledocholithiasis found intra-operatively
and to ERCP failures.10,62 In our series, we found resid-
ual choledocholithiasis in 4 patients.  These CBD stones
were successfully cleared with transcystic laparoscopic
techniques in 3 of 4 (75%) patients.  Other treatment
options for residual CBD stones post ERCP include expec-
tant therapy, repeat postoperative ERCP, or open CBD
clearance.  Factors which support spontaneous postoper-
ative passage of CBD stones include a single small stone,
no significant distal CBD stricture, duodenal filling during
cholangiogram, the serum bilirubin not rising since the
ERCP and the gastroenterologist feeling an adequate
sphincterotomy has been performed.  Studies have
shown that a stone greater than 1 cm or multiple stones
are significantly more difficult to clear with ERCP and
sphincterotomy, so we would not rely on repeat postop-
erative ERCP for stone clearance nor would we necessar-
ily expect these to pass spontaneously.63-64  Therefore, if
we detect a residual stone greater than 1 cm or multiple
stones during intraoperative cholangiography, we are
inclined to convert to open CBD exploration if laparo-
scopic CBD techniques have failed. 
CONCLUSIONS
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preoperative ERCP followed by LC is an effective strate-
gy.  Unnecessary ERCP can be avoided if strict clinical cri-
teria to reliably predict CBD stones is established and fol-
lowed (serum bilirubin in our institution).  Although
ERCP cannulation rate and the detection rate of choledo-
cholithiasis is high, residual stones are not uncommon
even after presumed successful ERCP.  These stones can
be detected with intraoperative cholangiography and, if
found, can be treated effectively with laparoscopic tech-
niques if the surgeon feels the stones will not pass spon-
taneously.
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